High Court Hears Breast Cancer Research Case
Myriad Genetics’ claim to the isolated BRCA gene is being closely watched. “I dearly hope the Supreme Court overturns this patent–doing so could, among other things, make complete testing more affordable,” says one breast cancer survivor.